Coagulation and fibrinolysis parameters in normal and in hypertensive pregnancies

Hypertension in Pregnancy

Volumn 17, Issue 2, 1998, Pages 115-123

  Bellart, Jordi ^a,d   Gilabert, Rosa ^a   Fontcuberta, Jordi ^b   Borrell, Montserrat ^b   Miralles, Ramon M ^a   Cabero, Lluis ^c  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Coagulation; Fibrinolysis; Heparin cofactor II; Preeclampsia; Pregnancy

Indexed keywords

ANTITHROMBIN; ANTITHROMBIN III; D DIMER; HEPARIN COFACTOR II; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN C; PROTEIN S; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; FIBRINOLYSIS; HUMAN; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; PUERPERIUM; THIRD TRIMESTER PREGNANCY;

EID: 0031857666     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641959809006068     Document Type: Article

References (13)

1. Weenink GH, Borm JJ, ten-Cate JW, Treffers PE. Antithrombin III levels in normotensive and hypertensive pregnancy. Gynecol Obstet Invest 1983;16:230-42.
2. De Boer K, ten-Cate JW, Sturk A, Borm, JJJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989; 160:95-100.
3. Terao T, Maki M, Ikenoue T, et al. The relationship between clinical signs and hypercoagulable state in toxemia in pregnancy. Gynecol Obstet Invest 1991;31: 74-85.
4. Caron C, Goudemand J, Marey A, et al. Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy associated hypertension. Thromb Haemost 1991;66:410-4.
5. Aznar J, Estelles A, Gilabert J. Modificacion de la hemostasia durante la gestacion, parto y puerperio. In: Gilabert J, Galbis M, Aznar J, Monleon J, eds. Clinica Ginecologica: Alteraciones de la Hemostasisa en Obstetricia. Barcelona: Salvat ed., 1988:90-102.
6. Gilabert J, Fernandez JA, España F, Aznar J, Estelles A. Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives. Thromb Res 1988;49:319-29.
7. Weiner CP, Brandt J. Plasma antithrombin III activity in normal pregnancy. Obstet Gynecol 1980;56:601-3.
8. Kobayashi T, Terao T. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin complexes and D-dimer. Gynecol Obstet Invest 1987;24:170-8.
9. Xu C, Zhou L, Shong S, et al. Antithrombin III activity in Chinese women in preeclampsia. Thromb Res 1990;59:401-6.
10. Reinthaller A, Mursch-Edlmayr G, Tatra G. Thrombin antithrombin complex levels in normal pregnancy with hypertensive disorders and after delivery. Br J Obstet Gynaecol 1990;97:506-10.
11. Andrew M, Mitchell L, Berry L, et al. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. J Clin Invest 1992;89:321-6.
12. Andersson TR. Consumption of heparin cofactor II (dermatan sulfate factor) and antithrombin during coagulation. Thromb Res 1987;46:355-62.
13. Bonnar J, McNicol GP, Douglas AS. Coagulation and fibrinolytic system in preéclampsia and eclampsia. Br Med J 1976;3:12-16.